Found 15 results

Name Type of Offering Accepted Date
EYEGATE PHARMACEUTICALS INC See All Filings
D 2019-10-08 16:06:12
Amount To Be Raised $1,875,000
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001144204-19-047664
Exclusions or Exemptions 506b
Accepted Date 2019-10-08 16:06:12
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
KIORA PHARMACEUTICALS INC See All Filings
D 2024-02-14 15:51:56
Amount To Be Raised $15,000,000
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001372514-24-000014
Exclusions or Exemptions 506b
Accepted Date 2024-02-14 15:51:56
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2009-12-21
Amount To Be Raised $22,641,695
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001140361-09-029853
Exclusions or Exemptions N/A
Accepted Date 2009-12-21
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2020-01-15 16:15:18
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001104659-20-004326
Exclusions or Exemptions 506b
Accepted Date 2020-01-15 16:15:18
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
KIORA PHARMACEUTICALS INC See All Filings
D 2023-02-17 16:32:20
Amount To Be Raised $200,000
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001104659-23-023307
Exclusions or Exemptions 506b
Accepted Date 2023-02-17 16:32:20
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2013-09-26
Amount To Be Raised $1,448,264
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001140361-13-037049
Exclusions or Exemptions 506b
Accepted Date 2013-09-26
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt
EYEGATE PHARMACEUTICALS INC See All Filings
D 2014-07-24
Amount To Be Raised $2,000,000
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001140361-14-029215
Exclusions or Exemptions 506b
Accepted Date 2014-07-24
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt
EYEGATE PHARMACEUTICALS INC See All Filings
D 2020-12-31 19:51:06
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001104659-20-141088
Exclusions or Exemptions 506b
Accepted Date 2020-12-31 19:51:06
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2011-01-05
Amount To Be Raised $4,450,648
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001140361-11-001123
Exclusions or Exemptions N/A
Accepted Date 2011-01-05
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2021-01-21 16:15:27
Amount To Be Raised $8,000,003
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001104659-21-006310
Exclusions or Exemptions 506b
Accepted Date 2021-01-21 16:15:27
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2021-11-04 16:20:13
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001104659-21-134407
Exclusions or Exemptions 506b
Accepted Date 2021-11-04 16:20:13
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2009-11-09
Amount To Be Raised $490,000
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0000929638-09-001539
Exclusions or Exemptions N/A
Accepted Date 2009-11-09
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
EYEGATE PHARMACEUTICALS INC See All Filings
D 2016-03-21
Amount To Be Raised $2,618,797
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001144204-16-089285
Exclusions or Exemptions 506b
Accepted Date 2016-03-21
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
EYEGATE PHARMACEUTICALS INC See All Filings
D 2016-07-07 16:16:45
Amount To Be Raised $3,768,750
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001144204-16-112000
Exclusions or Exemptions 506b
Accepted Date 2016-07-07 16:16:45
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
KIORA PHARMACEUTICALS INC See All Filings
D 2023-02-17 16:31:24
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001372514
Filed Document 0001104659-23-023304
Exclusions or Exemptions 506b
Accepted Date 2023-02-17 16:31:24
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity